Tapping nature's biosynthetic potential: Formation of the rare p-nitro benzoate precursor of aureothin, a mixed polyketide metabolite of Streptomyces thioluteus, requires two key enzymes: a p-amino benzoate synthase and an N-oxygenase. Feeding of surrogates to engineered block mutants (e.g. S. lividans ZX1::pHJ97) reveals that the iterative modular aureothin polyketide also accepts p-cyano benzoate as the starter, which is subsequently processed to the nitrile analogue of aureothin, aureonitrile, which has improved cytostatic properties.
No takes yet. Share an insight, caveat, or question.
Ziehl et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: